Researchers at the UW Carbone Cancer Center have set their sights on a protein biomarker that could help doctors more accurately predict which patients are helped by certain treatments.
This biomarker is part of the tumor microenvironment, or matrix, which is made up of the non-cancerous cells and tissues surrounding a cancerous growth.
“To understand who might benefit from immunotherapies, we need to know what controls the immune microenvironment and what controls the infiltration of T cells, and this study is a big step in that direction,” said Dusty Deming, a physician-researcher specializi...
Please log in to access subscriber content.
If you don't have a subscription, click here for a WisPolitics free trial and to view the different subscription options.